secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001824293-22-000007
Event type: leadership
Sentiment:  positive
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vallon Pharmaceuticals adds Meenu Karson to board; Ofir Levi steps down from committees
--------------------------------------------------------------------------------

- Board expanded from 5 to 6 directors; Meenu Karson appointed as independent director.
- Ofir Levi resigned from Audit and Nominating & Corporate Governance committees but remains Board Chair.
- Karson appointed to Audit Committee and as Chair of Nominating & Corporate Governance Committee.
- Karson is former President/CEO of Proteostasis Therapeutics, raised $300M+ and led IPO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429322000007/0001824293-22-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429322000007/ck00018242493-20220223.htm
  HTML page:      https://secwatch.observer/filing/0001824293-22-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer